HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia	Warm Antibody Autoimmune Hemolytic Anemia	Active, not recruiting	Phase 2 / Phase 3	2026-05-18		NCT05535933

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hutchmed	13

39 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Binzhou Medical College	Binzhou	China	3
Affiliated Hospital of Chengde Medical University	Chengde	China	5
Affiliated Hospital of Guangdong Medical University	Zhanjiang	China	14
Affiliated Hospital of Hebei University	Baoding	China	14
Affiliated Hospital of Nantong University	Nantong	China	14
Bethune First Hospital Of Jilin University	Changchun	China	1
Chenzhou First People's Hospital	Chenzhou	China	3
Fujian Medical University Union Hospital	Fuzhou	China	38
Fuyang Hospital Of Anhui Medical University	Fuyang	China	3
Guilin Medical College Affiliated Hospital	Guilin	China	1
Hainan General Hospital	Haikou	China	10
Harbin First Hospital	Harbin	China	3
Hematology Hospital of Chinese Academy of Medical Sciences	Tianjin	China	2
Henan Cancer Hospital	Zhengzhou	China	98
Heping Hospital Affiliated to Changzhi Medical College	Changzhi	China	6
Jiangsu Province Hospital	Nanjing	China	37
Jiangxi Provincial People's Hospital	Nanchang	China	9
Jinshan Hospital of Fudan University	Shanghai	China	1
Lanzhou University Second Hospital	Lanzhou	China	5
Nanfang Hospital	Guangzhou	China	16
Peking Union Medical College Hospital	Beijing	China	112
Qinghai provincial people's hospital	Xining	China	1
Shaanxi Provincial People's Hospital	Xi'an	China	11
Shenzhen Second People's Hospital	Shenzhen	China	17
The Affiliated Hospital of Southwest Medical University	Luzhou	China	11

Clinical trials